Can the therapeutic benefits of psilocybin be achieved without a psychedelic trip? What is the role of psychological support in the therapeutic effect of psilocybin? What is microdosing and what are its potential benefits and risks? What is the path to FDA approval and commercialization of psilocybin and other psychedelics?

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on the role of psychedelics in modern psychiatry.

Today, Dr. Andy Cutler interviews Dr. Charles Raison and Dr. Stephen Stahl about the importance of the psychedelic trip for the therapeutic benefits of psilocybin.

Let’s listen to Part 4 of our theme: Classic Psychedelics for the Modern Psychopharmacologist.

Subscribe to the NEI Podcast, so that you don’t miss another episode!

E213 - The PsychopharmaStahlogy Show: Is The Trip Necessary? with Dr. Charles Raison 01:01:33 Share

NEI Podcast

Shownotes Transcript

E213 - The PsychopharmaStahlogy Show: Is The Trip Necessary? with Dr. Charles Raison